Last updated: May 30, 2026
Suppliers for the pharmaceutical drug Akten (tadalafil): who manufactures, supplies, and distributes it?
Akten is a tadalafil brand. It is supplied through a mix of originator-level global manufacturing and local distribution, with final market availability typically driven by the country-specific marketing authorization holder and its contracted wholesalers.
Because “Akten” can refer to different products by market and spelling variants, a complete, accurate supplier map (manufacturers, MAH, fill-finish sites, and distribution partners) cannot be produced from the information available here.
Which company supplies Akten tadalafil in the US, EU, UK, and other markets?
Akten supply chains are territory-specific because:
- marketing authorization (MAH) is country-specific
- packaging labels and NDC/MA numbers differ by market
- wholesalers and parallel-import channels differ by region
What is the Orange Book status of Akten tadalafil, and does it list manufacturers?
The FDA’s Orange Book lists:
- the approved drug products
- application holders
- patent/EXCLUSIVITY and product-specific manufacturing data in some cases
A supplier determination requires that Akten’s exact US product identity be matched to the Orange Book entry (active ingredient, strength, dosage form, and applicant). That matching is not possible from the provided input.
What patents protect Akten tadalafil, and do suppliers change after generic entry?
Tadalafil product ecosystems typically include:
- drug substance and composition patents
- method-of-use patents (when claimed)
- formulation and crystal/polymorph patents (when applicable)
- manufacturing-process patents (less common in the final marketed products)
Supplier roles typically shift after generic launches because:
- multiple ANDA/marketed generics qualify as alternative sources
- distribution is re-tendered to wholesalers and local distributors
A supplier picture tied to patent entry dates also requires a specific, market-matched drug identity.
Which manufacturing sites produce Akten, and are there multiple fill-finish suppliers?
For solid oral tablets/capsules, common industry structures include:
- API manufacturer(s)
- tablet/capsule manufacturer(s)
- packaging and distribution partners by country
A verified list requires inspection of:
- MA dossier manufacturing sections
- local labeling
- traceable regulatory records and supplier declarations
No such records are available in the prompt.
How do parallel imports and re-packaging affect who the “supplier” is for Akten?
In many jurisdictions, Akten may appear via:
- authorized wholesalers
- parallel trade
- repackaging operations
This can cause apparent supplier variation even when the same marketing authorization holder is responsible. Determining the actual commercial supplier requires country-specific labeling and distributor records.
What generic or biosimilar risks exist for Akten, and do they affect supplier selection?
Tadalafil is small-molecule and is generally supported by generic competition rather than biosimilars. Supplier selection changes when:
- price-based tenders shift volume to the lowest-qualified source
- procurement favors manufacturers with reliable lot release and GMP track record
A credible risk and timing assessment needs an actual regulatory and market entry timeline for the specific Akten identity in each target country.
Key Takeaways
- “Akten” is a brand name for tadalafil, but supply chain partners are territory-specific.
- A complete, accurate list of suppliers (API, finished dose manufacturer, MAH, and distribution wholesalers) cannot be compiled from the provided input alone.
- Supplier mapping requires market-matched product identifiers (country labeling or regulatory entry) to avoid mixing unrelated “Akten” products or variants.
FAQs
- How can I identify the real manufacturer of Akten tadalafil on the package label?
- Do Akten suppliers differ by strength (e.g., 2.5 mg vs 5 mg vs 10 mg vs 20 mg)?
- Does Akten’s marketing authorization holder always equal the product manufacturer?
- How do wholesalers and parallel importers change the “supplier” seen in procurement?
- What regulatory documents usually list Akten’s manufacturing sites and packaging locations?
References
(No sources were cited because the prompt did not provide enough market- and product-specific identifiers to tie Akten to authoritative regulatory listings.)
